# Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters

> **NCT07056569** · NA · RECRUITING · sponsor: **Biokosmes Srl** · enrollment: 90 (estimated)

## Conditions studied

- Dermatitis, Contact
- Dermatitis
- Dermatitis, Chronic
- Dermatitis, Eczematous
- Dermatitis, Atopic Dermatitis

## Interventions

- **DEVICE:** 047_TD Dermatitis cream twice a day for 28 days

## Key facts

- **NCT ID:** NCT07056569
- **Lead sponsor:** Biokosmes Srl
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-05
- **Primary completion:** 2025-08
- **Final completion:** 2025-09
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07056569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07056569, "Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07056569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*